Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1968 2
1969 1
1971 5
1972 1
1975 2
1976 3
1977 1
1978 2
1979 1
1983 2
1984 2
1986 3
1987 3
1988 2
1990 3
1991 2
1992 6
1993 6
1994 8
1995 3
1996 4
1997 2
1998 2
1999 4
2000 4
2001 5
2002 7
2003 3
2004 6
2005 2
2006 2
2007 3
2008 11
2009 9
2010 6
2011 5
2012 9
2013 9
2014 7
2015 8
2016 13
2017 6
2018 13
2019 14
2020 9
2021 9
2022 13
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Results by year
Filters applied: . Clear all
Page 1
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, Baron A, Park JW, Han G, Jassem J, Blanc JF, Vogel A, Komov D, Evans TRJ, Lopez C, Dutcus C, Guo M, Saito K, Kraljevic S, Tamai T, Ren M, Cheng AL. Kudo M, et al. Among authors: evans trj. Lancet. 2018 Mar 24;391(10126):1163-1173. doi: 10.1016/S0140-6736(18)30207-1. Lancet. 2018. PMID: 29433850 Free article. Clinical Trial.
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies.
Motzer RJ, Taylor MH, Evans TRJ, Okusaka T, Glen H, Lubiniecki GM, Dutcus C, Smith AD, Okpara CE, Hussein Z, Hayato S, Tamai T, Makker V. Motzer RJ, et al. Among authors: evans trj. Expert Rev Anticancer Ther. 2022 Apr;22(4):383-400. doi: 10.1080/14737140.2022.2039123. Epub 2022 Apr 7. Expert Rev Anticancer Ther. 2022. PMID: 35260027 Free PMC article. Review.
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.
Naumann RW, Hollebecque A, Meyer T, Devlin MJ, Oaknin A, Kerger J, López-Picazo JM, Machiels JP, Delord JP, Evans TRJ, Boni V, Calvo E, Topalian SL, Chen T, Soumaoro I, Li B, Gu J, Zwirtes R, Moore KN. Naumann RW, et al. Among authors: evans trj. J Clin Oncol. 2019 Nov 1;37(31):2825-2834. doi: 10.1200/JCO.19.00739. Epub 2019 Sep 5. J Clin Oncol. 2019. PMID: 31487218 Free PMC article. Clinical Trial.
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Middleton MR, McAlpine C, Woodcock VK, Corrie P, Infante JR, Steven NM, Evans TRJ, Anthoney A, Shoushtari AN, Hamid O, Gupta A, Vardeu A, Leach E, Naidoo R, Stanhope S, Lewis S, Hurst J, O'Kelly I, Sznol M. Middleton MR, et al. Among authors: evans trj. Clin Cancer Res. 2020 Nov 15;26(22):5869-5878. doi: 10.1158/1078-0432.CCR-20-1247. Epub 2020 Aug 18. Clin Cancer Res. 2020. PMID: 32816891 Free PMC article. Clinical Trial.
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.
Bridgewater J, Fletcher P, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans TR, Stocken D, Stubbs C, Praseedom R, Ma YT, Davidson B, Neoptolemos J, Iveson T, Cunningham D, Garden OJ, Valle JW, Primrose J; BILCAP study group. Bridgewater J, et al. Among authors: evans tr. J Clin Oncol. 2022 Jun 20;40(18):2048-2057. doi: 10.1200/JCO.21.02568. Epub 2022 Mar 22. J Clin Oncol. 2022. PMID: 35316080 Clinical Trial.
Small Bowel Adenocarcinoma.
Aparicio T, Zaanan A, Mary F, Afchain P, Manfredi S, Evans TR. Aparicio T, et al. Among authors: evans tr. Gastroenterol Clin North Am. 2016 Sep;45(3):447-57. doi: 10.1016/j.gtc.2016.04.004. Gastroenterol Clin North Am. 2016. PMID: 27546842 Review.
Analyses of PD-L1 and Inflammatory Gene Expression Association with Efficacy of Nivolumab ± Ipilimumab in Gastric Cancer/Gastroesophageal Junction Cancer.
Lei M, Siemers NO, Pandya D, Chang H, Sanchez T, Harbison C, Szabo PM, Janjigian Y, Ott PA, Sharma P, Bendell J, Evans TRJ, de Braud F, Chau I, Boyd Z. Lei M, et al. Among authors: evans trj. Clin Cancer Res. 2021 Jul 15;27(14):3926-3935. doi: 10.1158/1078-0432.CCR-20-2790. Epub 2021 Mar 29. Clin Cancer Res. 2021. PMID: 33782030 Free article.
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
Finn RS, Kudo M, Cheng AL, Wyrwicz L, Ngan RKC, Blanc JF, Baron AD, Vogel A, Ikeda M, Piscaglia F, Han KH, Qin S, Minoshima Y, Kanekiyo M, Ren M, Dairiki R, Tamai T, Dutcus CE, Ikezawa H, Funahashi Y, Evans TRJ. Finn RS, et al. Among authors: evans trj. Clin Cancer Res. 2021 Sep 1;27(17):4848-4858. doi: 10.1158/1078-0432.CCR-20-4219. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108184 Free PMC article. Clinical Trial.
Telomerase-directed molecular therapeutics.
Keith WN, Bilsland A, Evans TR, Glasspool RM. Keith WN, et al. Among authors: evans tr. Expert Rev Mol Med. 2002 Apr 22;4(10):1-25. doi: 10.1017/S1462399402004507. Expert Rev Mol Med. 2002. PMID: 14987378 Review.
A community-sourced glossary of open scholarship terms.
Parsons S, Azevedo F, Elsherif MM, Guay S, Shahim ON, Govaart GH, Norris E, O'Mahony A, Parker AJ, Todorovic A, Pennington CR, Garcia-Pelegrin E, Lazić A, Robertson O, Middleton SL, Valentini B, McCuaig J, Baker BJ, Collins E, Fillon AA, Lonsdorf TB, Lim MC, Vanek N, Kovacs M, Roettger TB, Rishi S, Miranda JF, Jaquiery M, Stewart SLK, Agostini V, Stewart AJ, Izydorczak K, Ashcroft-Jones S, Hartmann H, Ingham M, Yamada Y, Vasilev MR, Dechterenko F, Albayrak-Aydemir N, Yang YF, LaPlume AA, Wolska JK, Henderson EL, Zaneva M, Farrar BG, Mounce R, Kalandadze T, Li W, Xiao Q, Ross RM, Yeung SK, Liu M, Vandegrift ML, Kekecs Z, Topor MK, Baum MA, Williams EA, Assaneea AA, Bret A, Cashin AG, Ballou N, Dumbalska T, Kern BMJ, Melia CR, Arendt B, Vineyard GH, Pickering JS, Evans TR, Laverty C, Woodward EA, Moreau D, Roche DG, Rinke EM, Reid G, Garcia-Garzon E, Verheyen S, Kocalar HE, Blake AR, Cockcroft JP, Micheli L, Bret BB, Flack ZM, Szaszi B, Weinmann M, Lecuona O, Schmidt B, Ngiam WX, Mendes AB, Francis S, Gall BJ, Paul M, Keating CT, Grose-Hodge M, Bartlett JE, Iley BJ, Spitzer L, Pownall M, Graham CJ, Wingen T, Terry J, Oliveira CMF, Millager RA, Fox KJ, AlDoh A, Hart A, van den Akker OR, Feldman G, Kiersz DA, Pomareda C, Krautter K, Al-Hoorie AH, Aczel B. Parsons S, et al. Among authors: evans tr. Nat Hum Behav. 2022 Mar;6(3):312-318. doi: 10.1038/s41562-021-01269-4. Nat Hum Behav. 2022. PMID: 35190714 Free article. No abstract available.
223 results